-
Mashup Score: 3Surgical removal of hematoma in ICH, disparities in neurodiagnosis for epilepsy, inequities among female neurology researchers - 6 day(s) ago
In this week’s podcast, Neurology Today’s editor-in-chief discusses a new study reporting better outcomes with surgical removal of hematoma in intracerebral hemorrhage, disparities in access to diagnosis and care for epilepsy, and the challenges that remain for women in neurology research.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 0Generative AI for personal statements, Match Day and neurology, AHS statement on CGRP-targeting therapies - 21 day(s) ago
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors’ response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 2ME/CFS and long COVID; negative outcomes for ALS drug; donanemab - 1 month(s) ago
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that explores an association between myalgic encephalomyelitis/chronic fatigue and long COVID; negative phase 3 findings on AMX0035 for ALS, and the pending approval of donanemab for Alzheimer’s disease.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 6
Neurology Today Editor-in-Chief Joseph E. Safdieh,MD, FAAN, highlights new research that casts doubt on the future of BTK inhibitors for MS, an assessment of the cost-effectiveness of lecanemab, and findings that COVID vaccines are not significantly associated with adverse neurologic events.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 6Biomarker for migraine; posterior cortical atrophy gene therapy for neuromuscular disorders - 3 month(s) ago
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses a new study showing retinal vascular perfusion as a migraine biomarker, clinical and pathophysiological correlates of posterior cortical atrophy, and advances in gene therapies for neuromuscular disorders.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 3DBS and cognition in severe TBI, in utero exposure to antiseizure drugs, best advances of 2023 - 5 month(s) ago
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on the impact of deep brain stimulation on cognition in severe traumatic brain injury and how adaptive functioning is impacted in children exposed to antiseizure drugs in utero, and the editorial board’s picks for the best advances of 2023.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 5Serotonin and long COVID, Afib detected 3 years after stroke, Medicare on PET amyloid scans - 6 month(s) ago
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies showing serotonin depletion associated with long COVID; implantable cardiac monitors detect Afib 3 years post-stroke; and what Medicare’s decision to cover PET amyloid scans means for neurologists.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 3A promising drug for refractory epilepsy; adverse childhood events and headache disorders; pathological engulfment by microglia in dementia. - 6 month(s) ago
Neurology Today Editor-in-chief Joseph E. Safdieh, MD, FAAN, discusses new studies on a promising potassium channel opener for refractory epilepsy; the impact of adverse childhood events in headache disorders; and excessive engulfment by microglia/astroctyes in dementia.
Source: traffic.libsyn.comCategories: General Medicine News, NeurologyTweet
Tune into the #NeurologyToday in 5 #podcast for a look at this week’s new issue with our editor in chief, @BrainHealthMD: https://t.co/7Lw2Lg5sxN #NeuroTwitter @AANMember https://t.co/k0Oqal1XVi